SCHEMBL265674

SCHEMBL265674

C[C@@H]1CCC(=O)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5306053 1.00 CA1 (1.00)
SCHEMBL265331 1.00
SCHEMBL37255 1.00
SCHEMBL29465872 1.00
SCHEMBL28883290 0.97
Water SCHEMBL28652816 0.97
Methyl Alcohol SCHEMBL23272001 0.95
Cyclohexane SCHEMBL29120104 0.93 CA1 (0.86)
Benzene SCHEMBL28655502 0.93 CA1 (0.86)
Dimethylamine SCHEMBL4684858 0.93 CA1 (0.86)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250212873-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-07-03 US claimed
EP-4482306-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-01 EP claimed
WO-2023192424-A1 VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-05 WO claimed
CN-121471055-A Method for synthesizing (R) -3-methylheptanoic acid 临沂大学 2026-02-06 CN disclosed
US-20250212873-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-07-03 US disclosed
CN-120142505-A Application of hydroxyapatite in pretreatment of fruit juice, sample pretreatment method and detection method of lactone compound in fruit juice 广州市名花香料有限公司 2025-06-13 CN disclosed
EP-4482306-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-01 EP disclosed
US-12037354-B2 Cyclic pantetheine derivatives and uses thereof VECTIVBIO COMET AG (CH) 2024-07-16 US disclosed
EP-4338761-A1 PERFUMING COMPOSITIONS Firmenich SA (CH) 2024-03-20 EP disclosed
WO-2023192424-A1 VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-05 WO disclosed
US-11730712-B2 Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease ESPERVITA THERAPEUTICS, INC. (US) 2023-08-22 US disclosed
US-20070043240-A1 Method for the synthesis of 4-hydroxyisoleucine and the derivatives thereof MIOSKOWSKI CHARLES 2007-02-22 US disclosed
WO-2006078724-A2 MACROCYCLIC ANALOGS FOR THE TREATMENT OF IMMUNOREGULATORY DISORDERS AND RESPIRATORY DISEASES ARRAY BIOPHARMA NC. (US) 2006-07-27 WO disclosed
US-20060160838-A1 Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases ARRAY BIOPHARMA INC. 2006-07-20 US disclosed
US-20060030719-A1 Cis-3,5-disubstituted-dihydro-furan-2-ones and the preparation and use thereof E. I. DU PONT DE NEMOURS AND COMPANY 2006-02-09 US disclosed
WO-2005014565-A2 CIS-3,5-DISUBSTITUTED-DIHYDRO-FURAN-2-ONES AND THE PREPARATION AND USE THEREOF E.I. DUPONT DE NEMOURS AND COMPANY (US) 2005-02-17 WO disclosed
WO-2003103653-A1 METHODS OF TREATING ALZHEIMER'S DISEASE USING ARYL ALKANOIC ACID AMIDES ELAN PHARMACEUTICALS, INC. (US) 2003-12-18 WO disclosed
EP-0478147-B1 Process for producing optically active gamma-butyrolactone derivatives TAKASAGO PERFUMERY CO LTD (JP) 1996-11-06 EP disclosed
US-5420306-A Process for producing optically active γ-butyrolactone derivatives TAKASAGO INTERNATIONAL CORPORATION (JP) 1995-05-30 US disclosed
EP-0478147-A1 Process for producing optically active gamma-butyrolactone derivatives Takasago International Corporation (JP) 1992-04-01 EP disclosed